Quest 10 Wealth Builders’s AstraZeneca AZN Stock Holding History

Quest 10 Wealth Builders’s Portfolio AZN Stock Details AZN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$9.8K	Hold	61	–	–	0.01%	481
2026 Q2	$11.6K	Hold	61	–	–	0.01%	424
2026 Q1	$12K	Sell	61 -1	-2%	-$193	0.01%	418
2025 Q4	$11.3K	Sell	62 -19	-23%	-$3.33K	0.01%	394
2025 Q3	$12.4K	Buy	81 +19	+31%	+$2.88K	0.01%	348
2025 Q2	$8.6K	Hold	62	–	–	0.01%	422
2025 Q1	$9.04K	Hold	62	–	–	0.01%	377
2024 Q4	$8.06K	Buy	+62	New	+$8.68K	0.01%	424

Other funds holding AZN

Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return

Amundi Paris, France $496B AUM 35.36% 1-Year Est. Return

Fisher Asset Management Camas, Washington $348B AUM 26.9% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $362B AUM 34.89% 1-Year Est. Return

Aviva London, United Kingdom $70.5B AUM 31.52% 1-Year Est. Return

Mitsubishi UFJ Trust & Banking Tokyo, Japan $47.2B AUM 26.24% 1-Year Est. Return

Fidelity International Hamilton, Bermuda $144B AUM 22.91% 1-Year Est. Return

Barclays London, United Kingdom $500B AUM 36.84% 1-Year Est. Return

Rathbones Group Liverpool, United Kingdom $28B AUM 17.3% 1-Year Est. Return

Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return

Quest 10 Wealth Builders's AZN Position: Q3 2026 in Review

Quest 10 Wealth Builders held its AstraZeneca (AZN) position steady in Q3 2026 at 61 shares worth $9.8K. The position accounts for 0.01% of the portfolio, ranked #481.

Quest 10 Wealth Builders first reported a position in AZN in Q4 2024 and has held it in 8 quarters since. The position peaked at $12.4K in Q3 2025. 941 funds tracked by Wall St. Rank hold AZN as of Q3 2026.

Quest 10 Wealth Builders held 61 shares of AstraZeneca worth $9.8K as of Q3 2026.
Quest 10 Wealth Builders left its AstraZeneca share count unchanged in Q3 2026.
AstraZeneca made up 0.01% of Quest 10 Wealth Builders's portfolio in Q3 2026, its #481 holding.
Quest 10 Wealth Builders first reported a position in AstraZeneca in Q4 2024 and has held it in 8 quarters since.
Quest 10 Wealth Builders's AstraZeneca position peaked at $12.4K in Q3 2025.
941 funds tracked by Wall St. Rank held AstraZeneca as of Q3 2026.

Based on Quest 10 Wealth Builders's 13F filing for Q3 2026, filed 2 Nov 2026.